—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Abbott Laboratories (ABT) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for ABT, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Strategy, “Covered Calls for Income — the Dividend Aristocrats Approach” (2026-05-22)

Mentioned on Closelooknet

Where ABT appears in the diary — 1 piece, newest first. Every link is our own writing.

Long reads

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.37 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How ABT has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.37 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Abbott Laboratories moved 0.37% on average · correlation 0.13 · higher than 36% of US names
  • Beta, last 3 months 0.49 about the same as over the year
  • On the 10 worst bond days −0.93% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −2.34% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ABT on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Abbott Laboratories

ABT in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Abbott Laboratories operates across four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. It makes generic drugs, diagnostic testing systems for laboratories and point-of-care settings, infant and adult nutrition products, and devices for cardiovascular disease, diabetes monitoring and neuromodulation. It is based in Abbott Park, Illinois, and sells across international markets.
Where it sits in the stack
Abbott holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's Healthcare sleeve, under medical devices, alongside diagnostics and pharmaceutical manufacturers.
Who it is priced against
The diary's peer group does not name a comparison set for Abbott; the market often compares it with Johnson & Johnson.
Why Closelooknet tracks it
Abbott holds a seat in the S&P 500 but not in our own Rubin index, and it does not yet carry a Closelooknet score. The diary has quoted it once, in a Strategy piece on covered calls across dividend aristocrats, grouping it among slow-compounding healthcare names.
What the diary watches
The diary watches whether Abbott's diagnostics and device segments keep offsetting each other as pandemic-era testing demand normalises.

Abbott Laboratories (ABT) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: ABT news on the tape · index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 2.45%, quarterly · last 0.63 USD on 2026-07-15

Dividends and capital return

What ABT pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.48 USD per share · a 2.45% yield on the 2026-09-25 close 4 distributions, paid quarterly 2026-09-25
  • Change on the year +6.6% against the prior twelve months prior twelve months 2.33 USD per share
  • Last distribution 0.63 USD per share as the price series records it, within days of the ex-date 2026-07-15
  • By calendar year 2023: 0.51 USD (partial) · 2024: 2.21 USD · 2025: 2.36 USD · 2026: 1.89 USD to date first distribution recorded in the three-year window: 2023-10-12

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Abbott Laboratories (ABT)?

Abbott Laboratories trades as ABT on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is ABT in a Closelooknet index?

Not currently — Abbott Laboratories is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does ABT trade against its moving averages?

Mixed moving-average stack: Trades -5.3% vs the 50-day and -2.8% vs the 200-day average, 24% below the 52-week high and +23.6% off the 52-week low; a golden cross printed 10 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Abbott Laboratories trade when bond yields rise?

Over the past year Abbott Laboratories had a beta of 0.37 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 36% of US names. On the 10 sessions in which long bonds fell most it moved −0.93% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Abbott Laboratories?

Abbott Laboratories appears in 1 Closelooknet piece, most recently Strategy: Covered Calls for Income — the Dividend Aristocrats Approach (2026-05-22). What Closelooknet said most recently: The list overlaps heavily with the consumer-staples / industrials / healthcare slow-compounders: KO, PG, JNJ, KMB, MMM, ED, ABT, MMC, EMR, ITW, and on. (Strategy, 2026-05-22). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does Abbott Laboratories do?

Abbott Laboratories operates across four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. It makes generic drugs, diagnostic testing systems for laboratories and point-of-care settings, infant and adult nutrition products, and devices for cardiovascular disease, diabetes monitoring and neuromodulation. It is based in Abbott Park, Illinois, and sells across international markets. The diary's peer group does not name a comparison set for Abbott; the market often compares it with Johnson & Johnson.

Where does Abbott Laboratories sit in the AI build-out?

Abbott holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's Healthcare sleeve, under medical devices, alongside diagnostics and pharmaceutical manufacturers. Abbott holds a seat in the S&P 500 but not in our own Rubin index, and it does not yet carry a Closelooknet score. The diary has quoted it once, in a Strategy piece on covered calls across dividend aristocrats, grouping it among slow-compounding healthcare names.

Does Abbott Laboratories pay a dividend?

Abbott Laboratories has paid 2.48 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.45% on the 2026-09-25 close; the last distribution recorded in the price series was 0.63 USD on 2026-07-15. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for ABT, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.